Featured Article
Quest Diagnostics, a U.S. healthcare diagnostic company, had a positive FY 2024. Revenue rose 6.7% to $9.87 billion, and earnings before interest and taxes rose 6.7% to $1.34 billion over the last year. A review of Quest Diagnostics’ 30 January 2025 earnings call and associated financial reports provided insight regarding the importance of pricing on performance. FACTS FROM EARNINGS CALL AND ANNUAL REPORT Pricing was not a topic discussed in their earnings…
Read MoreIn This Issue
Edwards Lifesciences, a global leader in structural heart innovation, reported a positive FY 2024. Revenue rose 8.6% to $5.4 billion and earnings…
Read More
LabCorp, a laboratory services company for medical providers, pharmaceuticals, and researchers, had a positive FY 2024. Revenue rose 7% to $13.0 billion,…
Read More
Moderna, a leader in mRNA medicine best known for its COVID vaccine, had a mixed FY 2024. Revenue fell 53% to $3.2…
Read More
Tariffs are in the news, but will they have no to little impact on inflation? What can we expect in the next…
Read More